التفاصيل البيبلوغرافية
| العنوان: |
Enhancing T‐cell responses to GCB‐like lymphomas with immune‐checkpoint‐blockade‐based therapies. |
| المؤلفون: |
Serganova, I., Bucktrout, R., Isshiki, Y., Sarapulov, A., Santella, A., Rodriguez, M., Chakraborty, S., Brunschvig, S., Qualls, D., Vardhana, S., Lesokhin, A., Melnick, A., Beguelin, W., Zappasodi, R. |
| المصدر: |
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p280-280, 1p |
| مصطلحات موضوعية: |
T cells, LYMPHOMAS, CYTOTOXIC T cells, REGULATORY T cells |
| مستخلص: |
Of note, normal B and/or GCB cells in lymphoma-bearing vs. control mice also downregulated MHC-II, pointing to aberrant B:CD4 SP + sp T-cell interactions overall. B Introduction: b Germinal center B-cell(GCB)-like diffuse large B-cell lymphomas and follicular lymphomas resemble GCB cells, which are normally controlled by CD4 SP + sp T follicular helper (Tfh) cells. Enhancing T-cell responses to GCB-like lymphomas with immune-checkpoint-blockade-based therapies. [Extracted from the article] |
|
Copyright of Hematological Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder